ADDLF News Today: Stay Updated with the Latest AddLife AB (publ) News in Real Time
Find ADDLF news now at Meyka AI. Stay informed with the latest{" "} AddLife AB (publ) stocks updates, including price news, market analysis, and expert insights.
LBGUF Earnings Beat: L E Lundbergföretagen Q2 2026 Results
LBGUF reported Q2 2026 earnings on May 21, 2026 with $2.02 EPS and $868.45M revenue. Meyka AI rates the stock B+.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD on PNK. Medical device company faces high valuation multiples despite strong 6-month gains of 40%.
BRCTF Earnings Beat: BioArctic AB (publ) Crushes Q2 2026 Estimates
BioArctic AB (BRCTF) beat Q2 2026 earnings on May 20 with EPS of $0.2514 vs. -$0.0316 estimate and $46.04M revenue vs. $20.26M expected.
NDRBF Earnings Beat: NIBE Industrier Q2 2026 Results
NDRBF beats EPS and revenue estimates in Q2 2026 earnings. NIBE Industrier reports $0.0263 EPS vs $0.0257 estimate, $1.02B revenue.
Beyond Frames Entertainment Stock Slips 1.9% Ahead of Earnings
8WP.F stock drops 1.9% to €0.207 on XETRA ahead of May 21 earnings announcement. Gaming firm faces profitability challenges.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD. Medical device maker faces elevated valuation metrics and mixed analyst outlook in healthcare sector.
BioArctic AB (BRCTF) Earnings Preview: EPS Seen at -$0.0316 on Q2 2026
BRCTF earnings preview: BioArctic AB (publ) reports May 20, 2026. EPS estimate -$0.0316, revenue $20.26M. Analyst expectations and key metrics.
Xvivo Perfusion Stock Holds at $6.54 Amid Organ Transplant Demand
XVIPY stock trades flat at $6.54 USD on PNK. Medical device maker Xvivo Perfusion focuses on organ preservation technology for transplantation.
CAMRF Camurus AB Earnings Miss: EPS Down 30.67%
Camurus AB (CAMRF) missed Q1 2026 earnings with EPS of $0.2532 vs. $0.3652 estimate and revenue of $56.24M vs. $65.12M expected.